4//SEC Filing
Hunt Hazel 4
Accession 0000950170-25-020219
CIK 0001088856other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 8:20 PM ET
Size
8.4 KB
Accession
0000950170-25-020219
Insider Transaction Report
Form 4
Hunt Hazel
Chief Scientific Officer
Transactions
- Tax Payment
Common Stock
2025-02-11$68.11/sh−85,176$5,801,337→ 183,405 total - Exercise/Conversion
Stock Option (right to buy)
2025-02-11−150,000→ 0 totalExercise: $3.29Exp: 2025-02-18→ Common Stock (150,000 underlying) - Exercise/Conversion
Common Stock
2025-02-11$3.29/sh+150,000$493,500→ 268,581 total
Footnotes (2)
- [F1]These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 18, 2025.
- [F2]Fully exercisable.
Documents
Issuer
CORCEPT THERAPEUTICS INC
CIK 0001088856
Entity typeother
Related Parties
1- filerCIK 0001698307
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 8:20 PM ET
- Size
- 8.4 KB